Speratum Competitors and Similar CompaniesClear all
Speratum's competitors and similar companies include Foghorn Therapeutics and ImmPACT-Bio.
 Speratum Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations HQ | Locations Cambridge, US HQ Cambridge, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 9 | Employees 1123% decrease | Employees 845% decrease |
Funding | |||
Latest funding round | Latest funding round $ 2m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised $ 2.8m | Total funding raised $ 50m | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company